Avaliação terapêutica do praziquantel (Embay 8440) na infecção humana pelo S. mansoni Therapeutical investigation of praziquantel in human infection due to Schistosoma mansoni

Avaliação terapêutica do praziquantel (Embay 8440) na infecção humana pelo S. mansoni Therapeutical investigation of praziquantel in human infection due to Schistosoma mansoni

Foram tratados com praziquantel, dose oral única de 40 ou 50 mg/kg, 200 indivíduos portadores de esquistossomose mansoni, matriculados na Clínica de Doenças Infecciosas e Parasitárias do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. As idades dos pacientes variavam de...

Full description

Bibliographic Details
Main Authors:	Silvino Alves de Carvalho, Vicente Amato Neto, José Murilo Robilotta Zeitune, Moisés Goldbaum, Euclides Ayres de Castilho, Rose Mary Grossman
Format:	Article
Language:	English
Published:	Universidade de São Paulo 1984-02-01
Series:	Revista do Instituto de Medicina Tropical de São Paulo
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651984000100008

Similar Items

Avaliação terapêutica do praziquantel (Embay 8440) na infecção humana pelo S. mansoni
by: Silvino Alves de Carvalho, et al.
Published: (1984-02-01)

THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
by: Adriana Maria B. MENDONÇA, et al.
Published: (2016-01-01)

Activity of praziquantel on in vitro transformed Schistosoma mansoni sporocysts
by: ACA Mattos, et al.
Published: (2006-10-01)

Altered Response of Strain of Schistosoma mansoni to Oxamniquine and Praziquantel
by: Patrícia Ivana Pires Bonesso-Sabadini, et al.
Published: (2002-04-01)

Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome
by: Pierre H. H. Schneeberger, et al.
Published: (2018-03-01)

The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype.
by: António Pinto-Almeida, et al.
Published: (2015-01-01)

Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.
by: Regina Coeli, et al.
Published: (2013-01-01)

Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model.
by: Nada Abla, et al.
Published: (2017-09-01)

Lethal effect of oxamniquine and praziquantel on mice experimentally infected with Schistosoma mansoni Efeito letal de oxamniquina e praziquantel em camundongos experimentalmente infectados com Schistosoma mansoni
by: Sonia Maria A.F. Tonelli, et al.
Published: (1995-08-01)

Evaluation of the Efficacy of Pediatric Suspension of Praziquantel against Schistosoma mansoni in Experimental Animals
by: Safaa M.M. Eassa, et al.
Published: (2017-12-01)

Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.
by: Sandra D Melman, et al.
Published: (2009-08-01)

Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms.
by: Giulliana T Almeida, et al.
Published: (2015-01-01)

Estudo da resistência do Schistosoma mansoni Sambon, 1907 ao praziquantel
by: Couto, Flávia Fernanda Bubula
Published: (2015)

Avaliação terapêutica do oltipraz na infecção humana pelo S. mansoni
by: Silvino Alves de Carvalho, et al.
Published: (1986-08-01)

Praziquantel-resistance in Schistosoma mansoni: role of efflux pumps, phenotypic characteristics and proteomics analysis
by: António Pinto Almeida
Published: (2019)

Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni
by: Naglaa Mohamed El-Lakkany, et al.
Published: (2011-11-01)

(Ca2+-Mg2+)ATPase in Schistosoma mansoni: evidence for heterogeneity and resistance to praziquantel
by: VMN Cunha, et al.
Published: (1998-01-01)

Morphological Characteristics of Schistosoma mansoni PZQ-resistant and -susceptible Strains are Different in Presence of Praziquantel
by: António ePinto-Almeida, et al.
Published: (2016-04-01)

Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
by: Amara RO, et al.
Published: (2018-08-01)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of <i>Schistosoma mansoni</i> Infection
by: Omary Mashiku Minzi, et al.
Published: (2021-04-01)

Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure.
by: Paul McCusker, et al.
Published: (2021-03-01)

Tratamento da esquistossomose mansônica hepatesplênica com praziquantel Treatment of hepatosplenic schistosomiasis mansoni with praziquantel
by: Amaury D. Coutinho, et al.
Published: (1984-02-01)

Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni
by: Neusa Araújo, et al.
Published: (2008-08-01)

Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni
by: Neusa Araujo, et al.
Published: (2008-12-01)

The antioxidants resveratrol and N-acetylcysteine enhance anthelmintic activity of praziquantel and artesunate against Schistosoma mansoni
by: Maria João Gouveia, et al.
Published: (2019-06-01)

Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails
by: Flávia FB Couto, et al.
Published: (2011-03-01)

Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
by: Jean T Coulibaly, et al.
Published: (2012-01-01)

Avaliação do efeito do praziquantel associado a lipossomas em Schistosoma mansoni in vivo
by: Frezza, Tarsila Ferraz, 1983-
Published: (2007)

Effect of maternal Schistosoma mansoni infection and praziquantel treatment during pregnancy on Schistosoma mansoni infection and immune responsiveness among offspring at age five years.
by: Robert Tweyongyere, et al.
Published: (2013-01-01)

Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
by: Beatrice Barda, et al.
Published: (2016-09-01)

Synergistic action of praziquantel and host specific immune response against Schistosoma mansoni at different phases of infection Ação sinergística do praziquantel e resposta imune específica do hospedeiro ao Schistosoma mansoni em diferentes fases da infecção
by: Fabio Ribeiro, et al.
Published: (2004-08-01)

Evaluation of Artesunate and Praziquantel Combination Therapy in Murine Schistosomiasis mansoni
by: Laila Abdel Moniem HEGAZY, et al.
Published: (2018-06-01)

The effects of subcurative praziquantel treatment on life‐history traits and trade‐offs in drug‐resistant Schistosoma mansoni
by: Mafalda Viana, et al.
Published: (2018-04-01)

Praziquantel is an effective drug for the treatment of Schistosoma Mansoni infection among school-aged children in Northwest Ethiopia
by: Addisu Tesfie, et al.
Published: (2020-04-01)

Evaluation of the bioassay of Commiphora molmol extract (Mirazid) against praziquantel in experimentally infected mice with Schistosoma mansoni
by: Mohammad Aziz, et al.
Published: (2017-06-01)

Efficacy and Safety of Praziquantel for Treatment of <i>Schistosoma mansoni</i> Infection among School Children in Tanzania
by: Rajabu Hussein Mnkugwe, et al.
Published: (2019-12-01)

Praziquantel sensitivity of Kenyan Schistosoma mansoni isolates and the generation of a laboratory strain with reduced susceptibility to the drug
by: Ibrahim N. Mwangi, et al.
Published: (2014-12-01)

Complementary effect of Capparis spinosa L. and silymarin with/without praziquantel on mice experimentally infected with Schistosoma mansoni
by: El-Hawary S. S., et al.
Published: (2018-03-01)

Evaluation of the Anti-schistosomal Effects of Turmeric (Curcuma longa) Versus Praziquantel in Schistosoma mansoni Infected Mice
by: Atef HUSSEIN, et al.
Published: (2017-12-01)

Avaliação da resposta terapêutica de um isolado murino de Schistosoma mansoni ao praziquantel: uma abordagem morfológica e biológica.
by: Silva, Michele Costa da
Published: (2013)